Inhibitory effect of deuterium oxide on cerebral vasospasm after experimental subarachnoid hemorrhage in a rabbit model

Neurological Research

Volumn 27, Issue 4, 2005, Pages 446-451

  Kaneko, Akira ^a   Moritake, Kouzo ^a   Kimura, Yoriyoshi ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Deuterium oxide; Rabbit; Subarachnoid hemorrhage; Treatment; Vasospasm

Indexed keywords

DEUTERIUM OXIDE; IOPAMIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BLOOD CLOT; BLOOD VESSEL DIAMETER; BRAIN; BRAIN ANGIOGRAPHY; BRAIN BLOOD FLOW; BRAIN VASOSPASM; CALCULATION; CISTERNA MAGNA; CONTROLLED STUDY; HISTOPATHOLOGY; INTIMA; MALE; NONHUMAN; RABBIT; RANDOMIZATION; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANGIOGRAPHY; ANIMALS; DEUTERIUM OXIDE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; RABBITS; RADIATION-PROTECTIVE AGENTS; RANDOM ALLOCATION; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 19544388560     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164105X49201     Document Type: Article

References (36)

1. Kassell, NF, Torner JC, Haley EJ, et al. The international cooperative study on the timing of aneurysm surgery. Part 1: overall management results. J Neurosurg 1990; 73: 18-36
2. Alabadi I, Torregrosa G, Miranda FJ, et al. Impairment of the modulatory role of nitric oxide on the Endothelin-1 elicited contraction of cerebral arteries: a pathogenic factor in cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1997; 41: 245-253
3. Hirose H, Sasaki T, Takahashi R, et al. The role of endothelium and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dogs. Eur J Pharmacol 1995; 277: 77-87
4. Macdonald NA, Weir BKA, Runzer TD, et al. Effect of intrathecal Superoxide dismutase and oxyhemoglobin-induced vasospasm in monkeys. Neurosurgery 1992; 30: 529-539
5. Minato H, Hashizume M, Masuda Y, et al. Modulation of extraluminally induced vasoconstriction by endothelium-derived nitric oxide in the canine basilar artery. Arzneimittelforsch 1995; 45: 675-678
6. Nakagomi T, Kassel NF, Sasaki T, et al. Effect of removal of the endothelium on vasoconstriction in canine and rabbit basilary arteries. J Neurosurg 1988; 68: 757-766
7. Macdonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991; 22: 971-982
8. Kaiminer B. Effect of heavy water on different types of muscle and on glycerol-extracted psoas fibres. Nature (Lond) 1960; 185: 172-173
9. 2+ channel. Nature 1987; 329: 243-246
10. Haurica I, Peculea M, Stefanescu I, et al. Effects of heavy and deuterium-depleted water on vascular reactivity. Rom J Physiol 1998; 35: 25-32
11. Wang R, Oster L, De Champlain J, et al. The vasorelaxant effect of deuterium oxide is secondary to calcium-induced liberation of nitric oxide by endothelial cells. J Hypertens 1993; 11: 1021-1030
12. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrate, in Vanhoutte PM, ed. Vasodilatation: vascular smooth muscle, peptide, autonomic nerves, and endothelium. New York: Raven Press, 1998: pp. 401-414
13. Kasuya H, Weir BKA, White DM, et al. Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg 1993; 79: 892-898
14. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Sci USA 1987; 84: 9265-9269
15. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526
16. Radomski MW, Palmer RMJ, Moncada S, Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181-187
17. Thompson BG, Pluta RM, Girton ME, et al. Nitric oxide mediation of chemoregulation but not autoregulation of cerebral blood flow in primates. J Neurosurg 1996; 84: 71-78
18. Ohlstein EH, Storer AG. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 1992; 77: 274-278
19. Sonobe M, Suzuki J. Vasospasmogenic substance produced following subarachnoid hemorrhage, and its fate. Acta Neurochir 1978; 44: 97-106
20. Gnarro LJ. Biosynthesis and metabolism of endothelium derived nitric oxide. Ann Rev Phamacol Toxicol 1990; 30: 535-560
21. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992; 32: 297-311
22. Edwards DH, Byrne JV, Griffith TM. The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg 1992; 76: 830-837
23. Katsuki S, Arnord W, Mittal C, et al. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin, and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucl Res 1977; 3: 23-25
24. Kim P, Schni VB, Sundt TM Jr, et al. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 1992; 70: 248-256
25. Kushner DJ, Baker A, Dunstall TG. Pharmacological uses and perspectives of heavy water and deuterated compounds. Can J Physiol Pharmacol 1999; 77: 79-88
26. Fisher JH, Knupfer P, Beyer M. Flush solution 2, a new concept for one-to-three-day hypothermic renal storage preservation. Transplantation 1985; 39: 122
27. Berwanger CS, Cleanthis TM, Hafez HM, et al. Deuterium oxide-based University of Wisconsin solution improves viability of hypothermically stored vascular tissue. Transplantation 1998; 65: 735-755
28. 2O) on the functional activity of human platelets. Haemostasis 1985; 15: 157-163
29. Satoh M, Perkins E, Kimura H, et al. Posttreatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse cerebral vasospasm in dogs. J Neurosurg 2002; 97: 136-142
30. Kimura H, Meguro T, Badr A, et al. Suramin-induced reversal of chronic cerebral vasospasm in experimental subarachnoid hemorrhage. J Neurosurg 2002; 97: 129-135
31. Vasdev S, Sampson CA, Longerich L, et al. Deuterium oxide prevents hypertension and elevated cytosolic calcium in hypertensive rats. Hypertension 1991; 18: 550-557
32. Kaminer B, Kimura J. Deuterium oxide: inhibition of calcium release in muscle. Science 1972; 176: 406-407
33. Wolf EW, Banerjee AB, Soble-Smith J, et al. Reversal of cerebral vasospasm using an intrathecally administrated nitric oxide donor. J Neurosurg 1998; 89: 279-288
34. Findlay JM, Weir BKA, Steinke D, et al. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 1988; 69: 723-735
35. Katz JJ, Crespi HL, Czajka DM, et al. Course of deuteriation and some physiological effects of deuterium in mice. Am J Physiol 1962; 203: 907-913
36. Wallance SA, Mathur JN, Allen BJ. The influence of heavy water on boron requirements for neuron capture therapy. Med Phys 1995; 22: 585-590